Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.57 USD | 0.00% | +5.02% | -14.67% |
May. 13 | TD Cowen Starts Biodesix With Buy Rating, $2.80 Price Target | MT |
May. 08 | Transcript : Biodesix, Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.67% | 178M | |
-22.04% | 8.54B | |
+67.43% | 4.32B | |
-0.82% | 2.53B | |
-39.22% | 2.48B | |
-8.53% | 1.9B | |
-17.35% | 1.59B | |
-40.70% | 1.23B | |
+13.38% | 1.13B | |
+16.15% | 994M |
- Stock Market
- Equities
- BDSX Stock
- News Biodesix, Inc.
- Biodesix Says Study Evaluating Nodify XL2 Test for Benign Lung Nodules Achieves Primary Endpoint; Shares Rise Pre-Bell